BINIMETINIB | ARRAY BIOPHARMA INC | ||
15MG | |||
Yes | No | ||
2033-Oct-18 | 2023-Jun-27 | ||
None | None | ||
None | No | ||
MEKTOVI is a kinase inhibitor indicated, in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test. |
0 | 2 | 0 |
Total Other Developers | 6 |
---|
Drugs with Suitability | No |
---|
15MG | ** | ** | - | - | - |
NDA Sales Available | Total Generic Sales Available |
---|---|
Yes | 0 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com